26th - 27th May 2022

2nd Annual MarketsandMarkets Biosimilars Conference


The Biosimilars industry is experiencing significant growth due to the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness. The global biosimilars market size is expected to grow from USD 35.7 billion by 2025 from USD 11.8 billion in 2020, at a CAGR of 24.7%. However, with complexities in manufacturing and resistance from biologic manufacturers, such factors keeps adding to the hinderance in their development.

3rd Annual MarketsandMarkets Biosimilars Conference will a hold discussions on key clinical attributes of biosimilars, perspective from different stakeholder regarding opportunities for the biosimilar market and how intense can the competition get.

The conference will also address perspective on global regulatory landscape and how partnerships can highly support R&D and production of biosimilars. Witness discussions on importance of market access and marketing strategy and how should companies enhance their presence in the market.

Key Highlights
  • Strategic framework and regulatory considerations
  • Key clinical attributes of Biosimilars
  • Expectations of biosimilars by different stakeholders
  • Market access and commercialization
Who Should Attend?

CEO, CSO, CMO, Director, VP, Head, Manager, and Research fellows from pharmaceutical and biotech company working in:

  • Biosimilar Research
  • Biosimilar Development
  • Clinical Development Unit
  • Regulatory Affairs
  • Medical Affairs and information
  • Scientific Affairs
  • Legal Affairs
  • Market Access
  • Licensing
  • Pricing strategy
  • Clinical Pharmacology
  • Clinical affairs/clinical operations
  • Commercial Development
  • Bioanalytics
Why Attend?
  • Learn about the recent trends and advancements affecting the biosimilars market
  • Learn about best practices for the commercial structure of a biosimilar from development to market access strategy
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical manufactures who will address most critical challenges in biosimilars upstream and downstream process
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading manufacturers, global regulators, and solution provider
About the Hotel